Select Publications
Journal articles
2024, 'Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer', iScience, 27, http://dx.doi.org/10.1016/j.isci.2024.110116
,2024, '4CAST: A phase 1b dose exploration, open-label, single-center study evaluating the safety of INO-464 in combination with chemotherapy in patients with metastatic breast cancer.', Journal of Clinical Oncology, 42, pp. e13112 - e13112, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e13112
,2024, 'Targeting androgen receptor signaling in glioblastoma: A novel biomarker and therapeutic approach.', Journal of Clinical Oncology, 42, pp. e14016 - e14016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e14016
,2024, 'Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME', Cancer Discovery, 14, pp. 643 - 647, http://dx.doi.org/10.1158/2159-8290.CD-23-1543
,2023, 'STEM-03. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA', Neuro-Oncology, 25, pp. v33 - v33, http://dx.doi.org/10.1093/neuonc/noad179.0130
,2023, 'Enhancing metabolite coverage in MALDI-MSI using laser post-ionisation (MALDI-2)', Analytical Methods, 15, pp. 4311 - 4320, http://dx.doi.org/10.1039/d3ay01046e
,2023, 'Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer', Advanced Science, 10, http://dx.doi.org/10.1002/advs.202301802
,2023, 'Abstract OT1-02-01: 4CAST: A Phase 1b dose exploration and dose expansion, open-label study evaluating the safety and efficacy of INO-464 in combination with Chemotherapy in patients with metASTatic breast cancer', Cancer Research, 83, http://dx.doi.org/10.1158/1538-7445.sabcs22-ot1-02-01
,2023, 'Single-cell multi-modal GAN reveals spatial patterns in single-cell data from triple-negative breast cancer', Patterns, http://dx.doi.org/10.1016/j.patter.2022.100577
,2022, 'Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning', Cancer Discovery, 12, pp. 1847 - 1859, http://dx.doi.org/10.1158/2159-8290.CD-21-0282
,2019, 'The complexities of metastasis', Cancers, 11, http://dx.doi.org/10.3390/cancers11101575
,2019, 'Unravelling the role of cell plasticity in BrCa development and metastasis', Oncology Abstracts, http://dx.doi.org/10.1530/oncolabs.1.p040
,2018, 'CD44 Orchestrates Metastatic Teamwork', Developmental Cell, 47, pp. 691 - 693, http://dx.doi.org/10.1016/j.devcel.2018.11.038
,2018, 'IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization', Nature Cell Biology, 20, pp. 1084 - 1097, http://dx.doi.org/10.1038/s41556-018-0173-5
,2018, 'An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer', eLife, 7, http://dx.doi.org/10.7554/eLife.37184
,2018, 'Recovering Gene Interactions from Single-Cell Data Using Data Diffusion', Cell, 174, pp. 716 - 729.e27, http://dx.doi.org/10.1016/j.cell.2018.05.061
,2017, 'Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells', Proceedings of the National Academy of Sciences of the United States of America, 114, pp. E2337 - E2346, http://dx.doi.org/10.1073/pnas.1618298114
,2016, 'EMT, cell plasticity and metastasis', Cancer and Metastasis Reviews, 35, pp. 645 - 654, http://dx.doi.org/10.1007/s10555-016-9648-7
,2015, 'Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness', Science, 348, pp. 340 - 343, http://dx.doi.org/10.1126/science.1260384
,2015, 'How does multistep tumorigenesis really proceed?', Cancer Discovery, 5, pp. 22 - 24, http://dx.doi.org/10.1158/2159-8290.CD-14-0788
,2013, 'Poised with purpose: Cell plasticity enhances tumorigenicity', Cell Cycle, 12, pp. 2713 - 2714, http://dx.doi.org/10.4161/cc.26075
,2013, 'XPoised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity', Cell, 154, pp. 61, http://dx.doi.org/10.1016/j.cell.2013.06.005
,2013, 'Cell plasticity and heterogeneity in cancer', Clinical Chemistry, 59, pp. 168 - 179, http://dx.doi.org/10.1373/clinchem.2012.184655
,2011, 'Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast', Cell, 145, pp. 926 - 940, http://dx.doi.org/10.1016/j.cell.2011.04.029
,2011, 'Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state', Proceedings of the National Academy of Sciences of the United States of America, 108, pp. 7950 - 7955, http://dx.doi.org/10.1073/pnas.1102454108
,2011, 'A perspective on cancer cell metastasis', Science, 331, pp. 1559 - 1564, http://dx.doi.org/10.1126/science.1203543
,2010, 'Cancer cell of origin: Spotlight on luminal progenitors', Cell Stem Cell, 7, pp. 271 - 272, http://dx.doi.org/10.1016/j.stem.2010.08.008
,2010, 'Disparate companions: Tissue engineering meets cancer research', Cells Tissues Organs, 192, pp. 141 - 157, http://dx.doi.org/10.1159/000308892
,2009, 'Cancer stem cells: Mirage or reality?', Nature Medicine, 15, pp. 1010 - 1012, http://dx.doi.org/10.1038/nm0909-1010
,2007, 'Aberrant fibroblast growth factor receptor signaling in bladder and other cancers', Differentiation, 75, pp. 831 - 842, http://dx.doi.org/10.1111/j.1432-0436.2007.00210.x
,2006, 'Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2', Cancer Research, 66, pp. 11271 - 11278, http://dx.doi.org/10.1158/0008-5472.CAN-06-2044
,2006, 'PPARγ-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma', BMC Cancer, 6, http://dx.doi.org/10.1186/1471-2407-6-53
,2005, 'Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder', Clinical and Experimental Metastasis, 22, pp. 115 - 125, http://dx.doi.org/10.1007/s10585-005-5141-3
,2002, 'The Feeding Response to Melanin-Concentrating Hormone Is Attenuated by Antagonism of the NPY Y1-Receptor in the Rat', Endocrinology, 143, pp. 191 - 197, http://dx.doi.org/10.1210/en.143.1.191
,